Jump to content

Draft:European Society for Radiation and Oncology

From Wikipedia, the free encyclopedia
  • Comment: Again, primary sources do not establish notability per WP:ORG. DoubleGrazing (talk) 11:46, 25 June 2024 (UTC)


ESTRO (The European Society for Radiotherapy and Oncology)[1] is a scientific society established in 1980 in Milan, Italy[2][3][4], founded by Maurice Tubiana, Jerzy Einhorn[5], Klaas Breur[6], Michael Peckham[7], and Emmanuel van der Schueren. It aims to advance radiation oncology to improve cancer treatment outcomes through education, research, and quality assurance. ESTRO is based in Brussels, Belgium. It is governed by an elected Board and has several committees focused on areas such as education, science, and clinical practice. The society collaborates with other oncology organizations and works to promote radiation oncology at the European level[8].

Main Activities[edit]

ESTRO supports its members through various initiatives:

  • Education: The ESTRO School offers a wide range of courses and workshops covering all aspects of radiation oncology.
  • Conferences: Annual ESTRO congresses and specialized meetings provide platforms for scientific exchange.
  • Publications: "Radiotherapy & Oncology"[9] is a peer-reviewed medical journal published by Elsevier on behalf of ESTRO, also known as "The Green Journal", to disseminate research findings.
  • Policy and Advocacy: ESTRO engages in public affairs activities to advocate for the importance of radiation oncology in cancer treatment. It publishes policy reviews and consensus statements in well-known journals[10].

ESTRO School[edit]

The ESTRO School provides multidisciplinary education through live courses, pre-meeting workshops, and hands-on experiences. It offers over 35 courses annually, attracting thousands of participants from around the world. The School also supports training through e-learning platforms like EAGLE and FALCON[11], which offer online courses and contouring workshops.

Annual Congresses[edit]

ESTRO's annual congresses are major events that attract thousands of delegates.[12] These congresses include scientific sessions, technical exhibitions, and opportunities for networking and professional development. The congresses promote the latest research and innovations in radiation oncology.[13][14]

References[edit]

  1. ^ Mayo, Charles S.; Moran, Jean M.; Bosch, Walter; Xiao, Ying; McNutt, Todd; Popple, Richard; Michalski, Jeff; Feng, Mary; Marks, Lawrence B.; Fuller, Clifton D.; Yorke, Ellen; Palta, Jatinder; Gabriel, Peter E.; Molineu, Andrea; Matuszak, Martha M. (2017-12-15). "American Association of Physicists in Medicine Task Group 263: Standardizing Nomenclatures in Radiation Oncology". International Journal of Radiation Oncology*Biology*Physics. 100 (4): 1057–1066. doi:10.1016/j.ijrobp.2017.12.013. PMC 7437157. PMID 29485047.
  2. ^ Colditz, Graham A. (2015-08-12). The SAGE Encyclopedia of Cancer and Society. SAGE Publications. p. 429. ISBN 978-1-4833-4574-1.
  3. ^ Overgaard, Jens; Baumann, Michael (2020-01-01). "Four decades with ESTRO". Radiotherapy and Oncology. 142: 1–5. doi:10.1016/j.radonc.2020.01.001. PMID 32007216.
  4. ^ Venselaar, Jack; Meigooni, Ali S.; Baltas, Dimos; Hoskin, Peter J. (2012-11-08). Comprehensive Brachytherapy: Physical and Clinical Aspects. Taylor & Francis. ISBN 978-1-4398-4499-1.
  5. ^ Hliniak, A. (2000). "In memoriam". Nowotwory. Journal of Oncology. 50 (5): 541. ISSN 2300-2115.
  6. ^ "Breur Award". Research Explorer The University of Manchester. Retrieved 2024-06-25.
  7. ^ "Professor Sir Michael Peckham, 1935 – 2021". www.icr.ac.uk. Retrieved 2024-06-25.
  8. ^ Kirby, A. M.; Guckenberger, M.; Slotman, B. J.; Clark, C. H.; Eriksen, J. G.; van der Heide, U.; De Ioanna, S.; Gasparotto, C.; Cortese, A. J.; ESTRO Board of Directors (2024-07-01). "European Society of Radiotherapy and Oncology (ESTRO) strategy 2024-2026: Growth and diversification in a rapidly changing world". Radiotherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology. 196: 110283. doi:10.1016/j.radonc.2024.110283. ISSN 1879-0887. PMID 38641262.
  9. ^ "ScienceDirect: Radiotherapy & Oncology".
  10. ^ Meattini, Icro; Becherini, Carlotta; Caini, Saverio; Coles, Charlotte E; Cortes, Javier; Curigliano, Giuseppe; de Azambuja, Evandro; Isacke, Clare M; Harbeck, Nadia; Kaidar-Person, Orit; Marangoni, Elisabetta; Offersen, Birgitte V; Rugo, Hope S; Salvestrini, Viola; Visani, Luca (2024-02-01). "International multidisciplinary consensus on the integration of radiotherapy with new systemic treatments for breast cancer: European Society for Radiotherapy and Oncology (ESTRO)-endorsed recommendations". The Lancet Oncology. 25 (2): e73–e83. doi:10.1016/s1470-2045(23)00534-x. hdl:2158/1353992. ISSN 1470-2045. PMID 38301705.
  11. ^ Eriksen, Jesper Grau; Salembier, Carl; Rivera, Sofia; De Bari, Berardino; Berger, Daniel; Mantello, Giovanna; Müller, Arndt-Christian; Martin, Arturo Navarro; Pasini, Danilo; Tanderup, Kari; Palmu, Miika; Verfaillie, Christine; Pötter, Richard; Valentini, Vincenzo (2014-07-25). "Four years with FALCON – An ESTRO educational project: Achievements and perspectives". Radiotherapy and Oncology. 112 (1): 145–149. doi:10.1016/j.radonc.2014.06.017. PMID 25070586.
  12. ^ "Glasgow welcomes over 6,500 delegates to the ESTRO Congress – The European Society for Radiotherapy and Oncology". Association of British Professional Conference Organisers. 1 May 2024. Retrieved 2024-06-25.
  13. ^ "BHU radiotherapy professor presents poster at European Conference". The Times of India. 2024-05-12. ISSN 0971-8257. Retrieved 2024-06-26.
  14. ^ "Medscape Coverage from European Society for Radiotherapy & Oncology (ESTRO 2017)". Medscape. Retrieved 2024-06-26.